secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2026-06-30T12:29:53+00:00
Accession:  0001437749-26-022087
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech reports warrant exercise for $2.7M; shares outstanding rise to 7.07M
--------------------------------------------------------------------------------

- Warrants to purchase 1,361,500 shares exercised, generating gross proceeds of ~$2.7 million.
- As of June 29, 2026, common shares outstanding total 7,065,000.
- Corporate presentation posted on company website; no material updates disclosed in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926022087/0001437749-26-022087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926022087/mbrx20260629_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-022087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer